Delivery Order SPE2DB20D3303-SPE2DB26FY1B5
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 8, 2025, for 60 tablets of Nucynta ER 200 mg. This firm fixed-price, competitively awarded contract carries a ceiling value of $2,411.52 and is scheduled for completion by September 9, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 26, 2025, for the supply of Nucynta ER 50 mg tablets (60-count units) with a contract value of $1,990.55. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The contract is set for ultimate completion by September 29, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,205.75 firm fixed-price delivery order by the Defense Logistics Agency on June 2, 2025, for Nucynta ER 200 mg tablets (60-count supply). The contract, which carries an ultimate completion date of June 3, 2025, represents a non-competitive award and serves the federal medical supply chain supporting military and veteran healthcare systems. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Nucynta ER 150 mg tablets (60-count units) with a contract ceiling value of $1,666.05. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award on October 6, 2025, for Nucynta ER Tabs 100mg with a ceiling value of $5,338.16. This firm fixed price delivery order, with an ultimate completion date of October 7, 2025, was competitively awarded without set-aside provisions to support the Defense Logistics Agency's Medical Supply Chain. The contract represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Nucynta ER 150 mg tablets (60-count units) with a contract ceiling value of $4,749.30. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open procurement process. The order is scheduled for ultimate completion on August 21, 2025, and will be fulfilled from AmerisourceBergen's corporate office...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 1, 2025, by the Defense Logistics Agency (DLA) for the supply of NUCYNTA ER 100 MG tablets (60-count packages) with a ceiling value of $9,298.18. The contract employs firm fixed price terms and is not subject to any set-aside designation, indicating competitive award status. This delivery order is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta ER 50 mg tablets (60-count) on September 22, 2025, with a ceiling value of $1,094.75 and an ultimate completion date of September 23, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's broader pharmaceutical...
- This delivery order, awarded on June 4, 2025, by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp, provides for the supply of Nucynta ER 150 mg tablets (60-count units) with a ceiling value of $2,849.58 under firm fixed pricing. The order is not set-aside and represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. AmerisourceBergen Drug Corp, a major healthcare solutions provider and critical vendor for federal...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $12,642.22 for Nucynta Tabs 75mg, a pain management pharmaceutical, by the Defense Logistics Agency's Medical Supply Chain on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and specifies performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB26FY1B5Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on October 22, 2025, for the supply of Nucynta ER 150 mg tablets (60-count units). This competitively awarded, non-set-aside contract carries a ceiling value of $1,960.50 and is structured as a firm fixed price delivery order with an ultimate completion date of October 23, 2025. The contract represents a fulfillment under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp's substantial IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of medications, vaccines, medical supplies, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs and other federal government healthcare systems worldwide. The company's role as a prime vendor through this contract arrangement demonstrates its critical position within the Defense Health Agency's medical supply chain, supporting procurement needs across the Department of Defense and related federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 10/22/25 |